KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer. Xiong Y, Ju L, Yuan L, Chen L, et al. Oncogene 2021 Jan 15. pii: 10.1038/s41388-020-01634.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiong Y, Ju L, Yuan L, Chen L, et al. KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer. Oncogene 2021 Jan 15. pii: 10.1038/s41388-020-01634.
PMID: 33452459